Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sanger Sequencing for BRCA1 c.68_69del, BRCA1 c.5266dup and BRCA2 c.5946del Mutation Screen on Pap Smear Cytology Samples.

International journal of molecular sciences·2016
Same author

A novel low temperature PCR assured high-fidelity DNA amplification.

International journal of molecular sciences·2013
Same author

Prevent cervical cancer by screening with reliable human papillomavirus detection and genotyping.

Cancer medicine·2013
Same author

Identification of a NodD repressible gene adjacent to nodM in Rhizobium leguminosarum biovar viciae.

Acta biochimica et biophysica Sinica·2012
Same author

The properties of NodD were affected by mere variation in length within its hinge region.

Acta biochimica et biophysica Sinica·2009
Same author

A small functional intramolecular region of NodD was identified by mutation.

Acta biochimica et biophysica Sinica·2009
Same journal

Functional Genomic Evidence for Candidate Small Viral RNA-Mediated Epigenetic Interference in SARS-CoV-1 and SARS-CoV-2.

Computational and structural biotechnology journal·2026
Same journal

From Pixels to Patterns: A Multidimensional Framework to Decode Cytoskeletal Organization.

Computational and structural biotechnology journal·2026
Same journal

A Large Concept Model for Mechanistic Simulation of Disease Trajectories: A Hypothesis-Generating Exemplar for Pediatric Acute Lymphoblastic Leukemia.

Computational and structural biotechnology journal·2026
Same journal

Adversarial Sequence Mutations in AlphaFold and ESMFold Reveal Nonphysical Structural Invariance, Confidence Failures, and Concerns for Protein Design.

Computational and structural biotechnology journal·2026
Same journal

High-Throughput Prediction of Protein-Protein Interactions Uncovers Hidden Molecular Networks in Biosynthetic Gene Clusters.

Computational and structural biotechnology journal·2026
Same journal

A Region-Aware Structured Framework Improves Prediction of Gene Expression from DNA Methylation.

Computational and structural biotechnology journal·2026
See all related articles

Related Experiment Video

Updated: May 31, 2025

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions
13:56

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions

Published on: July 18, 2013

11.1K

MTIOT: Identifying HPV subtypes from multiple infection data.

Qi Zhao1,2, Tianjun Zhou3, Lin Li1

  • 1Key Laboratory of Systems Biology, Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai 200031, China.

Computational and Structural Biotechnology Journal
|January 24, 2025
PubMed
Summary
This summary is machine-generated.

A new method, MTIOT, uses machine learning for more accurate high-risk human papillomavirus (hrHPV) detection. This advance in HPV-DNA testing offers improved cervical cancer screening and early detection capabilities.

Keywords:
Cervical carcinomaConvolutionHPVMachine Learning

More Related Videos

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

12.4K
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

10.3K

Related Experiment Videos

Last Updated: May 31, 2025

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions
13:56

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions

Published on: July 18, 2013

11.1K
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

12.4K
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

10.3K

Area of Science:

  • Oncology
  • Virology
  • Biotechnology

Background:

  • Persistent high-risk human papillomavirus (hrHPV) infection is a primary cause of cervical cancer.
  • Current HPV-DNA testing methods have limitations in sensitivity, accuracy, and comprehensive hrHPV typing.

Purpose of the Study:

  • To introduce MTIOT (Multiple subTypes In One Time), a novel detection method for enhanced HPV-DNA analysis.
  • To address the limitations of existing HPV testing for improved cervical cancer screening.

Main Methods:

  • Development of MTIOT, a machine learning-based detection method with a multichannel integration scheme.
  • Validation of MTIOT using simulated and clinical samples for hrHPV subtype identification.

Main Results:

  • MTIOT achieved high F1 scores of 98% on simulated samples and 92% on clinical samples for subtype identification (sample size ≥50).
  • The method demonstrates potential for more accurate and rapid identification of multiple hrHPV types in a single sample.

Conclusions:

  • MTIOT offers a potentially more efficient and cost-effective solution for cervical cancer screening.
  • This advancement in molecular diagnosis of hrHPV may significantly improve early detection strategies and reduce cervical cancer incidence.
  • Further clinical trials are needed to validate MTIOT's practical efficacy.